» Articles » PMID: 29113398

Combing NLR, V20 and Mean Lung Dose to Predict Radiation Induced Lung Injury in Patients with Lung Cancer Treated with Intensity Modulated Radiation Therapy and Chemotherapy

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Nov 9
PMID 29113398
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose was to evaluate the predictive value of baseline neutrophil to lymphocyte ratio (NLR) level in the incidence of grade 3 or higher radiation induced lung injury (RILI) for lung cancer patients. A retrospectively analysis with 166 lung cancer patients was performed. All of the enrolled patients received chemoradiotherapy at our hospital between April 2014 and May 2016. The Cox proportional hazard model was used to identify the potential risk factors for RILI. In this cohort, the incidence of grade 3 or higher RILI was 23.8%. Univariate analysis showed that radiation dose, volume at least received 20Gy (V20), mean lung dose and NLR were significantly associated with the incidence of grade 3 or higher RILI ( = 0.012, 0.008, 0.012, and 0.039, respectively). Multivariate analysis revealed that total dose ≥ 60 Gy, V20 ≥ 20%, mean lung dose ≥ 12 Gy, and NLR ≥ 2.2 were still independent predictive factors for RILI ( = 0.010, 0.043, 0.028, and 0.015, respectively). A predictive model of RILI based on the identified risk factors was established using receiver operator characteristic curves. The results demonstrated that the combination analysis of V20, mean lung dose and NLR was superior to either of the variables alone. Additionally, we found that the constraint of V20 and mean lung dose were meaningful for patients with higher baseline NLR level. If the value of V20 and mean lung dose lower than the threshold value, the incidence of grade 3 or higher RILI for the high NLR level patients could be decreased from 63.3% to 8.7%. Our study showed that radiation dose, V20, mean lung dose and NLR were independent predictors for RILI. Combination analysis of V20, mean lung dose and NLR may provide a more accurate model for RILI prediction.

Citing Articles

Dosimetric Predictors of Acute Radiation Pneumonitis and Esophagitis in Hypofractionated Thoracic Irradiation of Non-Small Cell Lung Cancer Patients With Poor Prognostic Factors.

Kenndoff S, Nieto A, Guggenberger J, Taugner J, Mansoorian S, Kasmann L Adv Radiat Oncol. 2025; 10(2):101682.

PMID: 39896724 PMC: 11786736. DOI: 10.1016/j.adro.2024.101682.


Dosimetric Planning Comparison for Left Ventricle Avoidance in Non-small Cell Lung Cancer Radiotherapy.

Chau O, Gaede S Cureus. 2025; 16(12):e76543.

PMID: 39877766 PMC: 11772094. DOI: 10.7759/cureus.76543.


Impact of the neutrophil-to-lymphocyte ratio on patients with locally advanced non-small cell lung cancer who suffer radiation pneumonitis during the course of induction chemoradiotherapy followed by surgery.

Kubo Y, Yamamoto H, Matsubara K, Hashimoto K, Tanaka S, Shien K Surg Today. 2024; 54(9):995-1004.

PMID: 38451313 DOI: 10.1007/s00595-024-02816-y.


Application of dose-gradient function in reducing radiation induced lung injury in breast cancer radiotherapy.

Bai H, Song H, Li Q, Bai J, Wang R, Liu X J Xray Sci Technol. 2024; 32(2):415-426.

PMID: 38189733 PMC: 11091614. DOI: 10.3233/XST-230198.


[Research Progress on the Protective Effect of Intestinal Flora on 
Radiation-induced Lung Injury in Thoracic Tumors].

Liu G, E M Zhongguo Fei Ai Za Zhi. 2023; 26(6):467-472.

PMID: 37488084 PMC: 10365960. DOI: 10.3779/j.issn.1009-3419.2023.106.11.


References
1.
Stenmark M, Cai X, Shedden K, Hayman J, Yuan S, Ritter T . Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys. 2012; 84(2):e217-22. PMC: 3646089. DOI: 10.1016/j.ijrobp.2012.03.067. View

2.
Berardi R, Rinaldi S, Santoni M, Newsom-Davis T, Tiberi M, Morgese F . Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy. Oncotarget. 2016; 7(18):26916-24. PMC: 5042025. DOI: 10.18632/oncotarget.8309. View

3.
Vogelius I, Bentzen S . A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol. 2012; 51(8):975-83. PMC: 3557496. DOI: 10.3109/0284186X.2012.718093. View

4.
Yorke E, Jackson A, Rosenzweig K, Braban L, Leibel S, Ling C . Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys. 2005; 63(3):672-82. DOI: 10.1016/j.ijrobp.2005.03.026. View

5.
Herter J, Kraft F, Van Aken H, Meersch M, Zarbock A, Rossaint J . GDF-15 prevents ventilator-induced lung injury by inhibiting the formation of platelet-neutrophil aggregates. Thromb Haemost. 2015; 114(2):434-7. DOI: 10.1160/TH14-12-1060. View